Learn More
Medchemexpress LLC Enasidenib mesylate | 1650550-25-6 | MFCD30489472 | 99.9% | 569.48 g/mol | C20H21F6N7O4S | 10 MG

Supplier: Medchemexpress LLC HY18690A10MG
Enasidenib mesylate is a reversible, selective inhibitor of mutant isocitrate dehydrogenase 2 (IDH2) used in research to study IDH2-mutant leukemia biology and differentiation. It reverses mutant IDH2-mediated epigenetic changes and impairs self-renewal of mutant leukemia cells. Supplied as a high-purity solid for in vitro applications.
- Potent, reversible inhibitor of mutant IDH2.
- Reverses mutant IDH2 effects on DNA methylation.
- High purity suitable for biochemical and cellular assays.
- Solid form for stable storage and handling.
- Recommended solvent: DMSO for sample preparation.
- Store sealed, away from moisture to maintain stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.